Lilly(Eli) (LLY) EPS (2013 - 2026)
Lilly(Eli) (LLY) EPS from Mar 31, 2013 to Mar 31, 2026. The TTM Lilly(Eli) (LLY) EPS is $23.87. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Lilly(Eli) (LLY) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +179.51% |
| 3 Years TTM | +70.96% |
| 5 Years TTM | +36.56% |
| 10 Years TTM | +28.20% |
| All Time TTM | +17.81% |
Annual EPS change of Lilly(Eli) (LLY)
| Year | EPS | Change |
|---|---|---|
| 2026 | $8.27 | -64.05% |
| 2025 | $23 | +95.62% |
| 2024 | $11.76 | +102.01% |
| 2023 | $5.82 | -15.95% |
| 2022 | $6.93 | +12.53% |
| 2021 | $6.15 | -9.81% |
| 2020 | $6.82 | -23.62% |
| 2019 | $8.93 | +184.10% |
| 2018 | $3.14 | -1720.98% |
| 2017 | -$0.19 | -126.60% |
| 2016 | $0.73 | -67.85% |
| 2015 | $2.27 | +1.51% |
| 2014 | $2.23 | -48.45% |
| 2013 | $4.33 | +18.01% |
| 2012 | $3.67 | -5.90% |
| 2011 | $3.90 | -14.86% |
| 2010 | $4.58 | +16.32% |
| 2009 | $3.94 | -308.20% |
| 2008 | -$1.89 | N/A |
Comparison Lilly(Eli) (LLY) five years EPS CAGR with competitors
Lilly(Eli) (LLY) five years EPS CAGR is 29.14%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 98.59% | +238.31% |
| NVO | Novo Nordisk | 24.26% | -16.76% |
| AZN | Astrazeneca plc | 17.09% | -41.34% |
| NVS | Novartis AG | 14.96% | -48.67% |
| JNJ | Johnson & Johnson | 11.59% | -60.23% |
| MRK | Merck & Co Inc | 5.37% | -81.57% |
| BMY | Bristol-Myers Squibb Company | 5.08% | -82.56% |
| GSK | GSK Plc | 4.65% | -84.04% |
| AMGN | AMGEN Inc | 3.49% | -88.01% |